检验医学与临床2017，Vol.14Issue(12)：1752-1753,2.DOI:10.3969/j.issn.1672-9455.2017.12.025
FEC及TC方案在乳腺癌新辅助化疗中的疗效及经济性研究
Research on efficacy and economy of FEC and TC scheme in neoadjuvant chemotherapy for breast cancer
胡月 1马满玲1
作者信息
- 1. 哈尔滨医科大学附属第一医院药学部,哈尔滨150001
- 折叠
摘要
Abstract
Objective To explore the curative eftect and economy ot FE-C and TC schemes in neoadjuvant cnemotherapy for breast cancer.Methods The data in 90 cases of breast cancer in our hospital were retrospectively analyzed.The patients were divided into the FEC group(fluorouracil,epirubicin and cyclophosphamide) and TC(docetaxel and cyclophosphamide) group according to the different treatment schemes.Then curative effect and economy were compared between the two groups.Results The effective rate of the FEC group was 46.7 ％,which of TC group was 44.4 ％ (P＞0.05);the costs of the FEC group and TC group were 755.97 Yuan and 2 622.91 Yuan respectively (P＜0.05).Conclusion Adopting the FEC and TC schemes in neoadjuvant chemotherapy of breast cancer have the same effect,but the curative cost of the FEC group is relatively small and is worth promotion.关键词
乳腺癌/FEC方案/TC方案/成本研究Key words
breast cancer/FEC scheme/TC scheme/cost study引用本文复制引用
胡月,马满玲..FEC及TC方案在乳腺癌新辅助化疗中的疗效及经济性研究[J].检验医学与临床,2017,14(12):1752-1753,2.
